Grossesse et insuffisance rénale chronique : quelle prise en charge en 2023 ? [Pregnancy and chronic renal failure: what is new in 2023?]

Fiche du document

Date

1 mars 2023

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.816.401

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36876389

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_14DB22FD05C16

Licences

info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-09-01 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/


Résumé 0

Chronic renal failure (CRF) during pregnancy increases the risk of fetomaternal complications such as preeclampsia, premature delivery and, above all, a deterioration of renal function. A multidisciplinary preconceptional assessment is necessary in this complex clinical situation. Progress in neonatal resuscitation and a better understanding of the pathophysiological mechanisms of autoimmune nephropathy have improved the prognosis of these high-risk pregnancies. This article provides an overview of the issues related to the follow-up of pregnant women with renal disease. It summarizes the glomerular and hemodynamic physiological changes during pregnancy, the fetal and maternal risk, and the adaptation of antihypertensive and immunosuppressive drug treatments.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en